We're obsessed with the details like selecting the most bioavailable form and precise dose, all built upon hard clinical data. We ensure the results you can feel, and every milligram is there for a reason.
Clinically Proven Benefits
The Science Behind
Our Ingredients
1. National Institutes of Health. Magnesium: Fact Sheet for Consumers. NIH Office of Dietary Supplements. March 22, 2021. Accessed February 4, 2026.
2. Abbasi B, Kimiagar M, Sadeghniiat K, et al. The effect of magnesium supplementation on primary insomnia in elderly: a double-blind placebo-controlled clinical trial. J Res Med Sci. 2012;17(12):1161-1169.
3. Rawji A, Peltier M, Mourtzanakis K, et al. Examining the effects of supplemental magnesium on self-reported anxiety and sleep quality: a systematic review. Cureus. 2024;16(4):e59317. doi:10.7759/cureus.59317.
4. Totten MS, Davenport TS, Edwards LF, Howell JM. Trace minerals and anxiety: a review of zinc, copper, iron, and selenium. Dietetics. 2023;2(1):83-103. doi:10.3390/dietetics2010008.
5. National Institutes of Health. Zinc: Fact Sheet for Consumers. NIH Office of Dietary Supplements. October 4, 2022. Accessed February 4, 2026.
6. National Institutes of Health. Vitamin B6: Fact Sheet for Health Professionals. NIH Office of Dietary Supplements. June 16, 2023. Accessed February4,2026.
7. Afshar S, Goudarzvandi S, Azam M, Rajaei Z, Rezaei N. The role of magnesium in sleep disorders: a systematic review. Biomed Pharmacother. 2024;174:116492. doi:10.1016/j.biopha.2024.116492.
8. Beardsley WR, Barker RW. Decreased plasma zinc receptors in children with anxiety disorders. J Clin Psychol. 1998;54(4):487-491.
9. Russo AJ. Dietary zinc and behavioral deficit. Nutr Neurosci. 2011;14(6):271-275.doi:10.1179/1476830511Y.0000000018.
10. Russo AJ. Decreased zinc and increased copper in individuals with anxiety. ClinBiochem.2007;40(12):1205-1208.doi:10.1016/j.clinbiochem.2007.07.012.
1. Russo M, Porcaro G, Aragona C, Bilotta G, Di Liberto M, Unfer V. The combination of diosgenin, vitamin D, and α-lactalbumin normalizes the menstrual cycle in women with PCOS of phenotype D: a pilot clinical study. Nutrients. 2025;17(23):3695. doi:10.3390/nu17233695.
2. Bila J, Dotlic J, Andjic M, et al. Obesity as a part of polycystic ovary syndrome (PCOS)—a review of pathophysiology and comprehensive therapeutic strategies. JClinMed.2024;14(16):5642. doi:10.3390/jcm14165642.
3. Szczuko K, Korylowicz J, Zapałowska-Chwyć M, Szczuko M. Polycystic ovary syndrome and nutritional management: a review. Nutrients. 2023;15(8):1852. doi:10.3390/nu15081852.
4. Mizgier M, Jeszka J, Jarzabek-Bielecka G. Nutrients and dietary supplements in the supportive treatment of polycystic ovary syndrome. Nutrients. 2021;13(2):412. doi:10.3390/nu13020412.
5. Maktabi M, Jamilian M, Jamilian M, Asemi Z, Esmaillzadeh A. The effects of magnesium, zinc, calcium, and vitamin D co-supplementation on biomarkers of inflammation, oxidative stress, and gene expression related to insulin and lipid in women with polycystic ovary syndrome. Int J Prev Med. 2019;10:116. doi:10.4103/ijpvm.IJPVM_200_18.
6. Ambrose C. Study investigates inositol’s potential to support endometrial health. CASI. Published September 1, 2023. Accessed February 4,2026.
7. Ambrose C. Recent review explores potential link between inositol and mood health. CASI. Published April 28, 2023. Accessed February 4, 2026.
8. Jurgelewicz M. New review investigates the role of myo-inositol in male fertility. CASI. Published November 1, 2019. Accessed February 4, 2026.
9. Jurgelewicz M. New meta-analysis investigates the effects of myo-inositol on metabolic parameters. CASI. Published July 29, 2019. Accessed February 4, 2026.
10. Ambrose C. New study evaluates inositol for the prevention of gestational diabetes. CASI. Published June 28, 2019. Accessed February 4, 2026.
1. Xu X, Yi H, Wu J, et al. Therapeutic effect of berberine on metabolic diseases: both pharmacological data and clinical evidence. Biomed Pharmacother. 2021;133:110984. doi:10.1016/j.biopha.2020.110984.
2. Wang H, Zhang H, Gao Z, Zhang Q, Gu C. The mechanism of berberine alleviating metabolic disorder based on gut microbiome. Front Cell Infect Microbiol. 2022;12:854885. doi:10.3389/fcimb.2022.854885.
3. Feng W, Wang WN, Chen PY, Du BY, Li HL. Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics. Theranostics. 2019;9(7):1923-1951. doi:10.7150/thno.30787.
4. Moon JM, Ratliff KM, Hagele AM, et al. Absorption kinetics of berberine and dihydroberberine and their impact on glycemia: a randomized, controlled, crossover pilot trial. Nutrients. 2021;14(1):124. doi:10.3390/nu14010124.
5. Bozic I, Lavrnja I. Thiamine and benfotiamine: Focus on their therapeutic potential. Heliyon.2023;9(11):e21839.doi:10.1016/j.heliyon.2023.e21839.
6. Balakumar P, Rohilla A, Krishan P, Solairaj P, Thangathirupathi A. The multifaceted therapeutic potential of benfotiamine. Pharmacol Res. 2010;61(6):482-488. doi:10.1016/j.phrs.2010.02.008.
7. Bönhof GJ, Sipola G, Strom A, et al. BOND study: a randomised double-blind, placebo-controlled trial over 12 months to assess the effects of benfotiamine on morphometric, neurophysiological and clinical measures in patients with type 2 diabetes with symptomatic polyneuropathy. BMJ Open.2022;12(2):e057142.doi:10.1136/bmjopen-2021-057142.
8. Gibson GE, Luchsinger JA, Cirio R, et al. Benfotiamine and cognitive decline in Alzheimer's disease: results of a randomized placebo-controlled phase IIa clinical trial. J Alzheimers Dis. 2020;78(3):989-1010. doi:10.3233/JAD-200896.
9. Sharma S, Shukla MK, Sharma KC, et al. Revisiting the therapeutic potential of gingerols against different pharmacological activities. Naunyn Schmiedebergs Arch Pharmacol. 2023;396(4):633-647. doi:10.1007/s00210-022-02372-7.
10. Attari VE, Mahdavi AM, Javadivala Z, et al. A systematic review of the anti-obesity and weight lowering effect of ginger (Zingiber officinale Roscoe) and its mechanisms of action. Phytother Res. 2018;32(4):577-585. doi:10.1002/ptr.5986.
11. Rodríguez-Morán M, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2003;78(4):447-452. doi:10.1093/ajcn/78.4.447.
12. National Center for Complementary and Integrative Health. Ginger. National Institutes of Health. Updated February 2025. Accessed February 4, 2026.
13. Higashikawa F, Nakaniida Y, Li H, et al. Beneficial effects of ginger extract on eye fatigue and shoulder stiffness: a randomized, double-blind, and placebo-controlled parallel study. Nutrients. 2024;16(16):2715. doi:10.3390/nu16162715.
14. Wang J, Ke W, Bao R, Hu X, Chen F. Ginger and its constituents: role in treatment of metabolic syndrome. Nutrients. 2020;12(4):1141. doi:10.3390/nu12041141.
15. Zhang XF, Guo SY, Wu JM, et al. Mechanism of ginger and its active ingredients in the treatment of metabolic syndrome. Chin J Integr Med. 2024;30(8):754-768. doi:10.1007/s11655-024-3604-x.
16. Yang M, Wu J, Zhang X, et al. Ginger and its active constituents in obesity and related metabolic disorders. Nutrients. 2022;14(23):4991. doi:10.3390/nu14234991.
Frequently Asked
Questions
This is the key scientific step in how we achieve "Smarter Formulas". Our goal is to ensure that the formulas you receive are completely harmonious, only generating synergistic effects rather than bringing about physical chaos or burden.
During the R&D phase, we conduct a comprehensive and stringent review and validation of clinical reports. Only ingredients with repeatedly verified and confirmed efficacy are included in the formula. We synergize the best clinically proven combinations, utilizing innovative formulations to optimize the overall effect and improve upon the shortcomings of a single ingredient.
The studies presented here mainly come from authoritative scientific and medical journals, all of which are independent, peer-reviewed clinical trials. Although some studies may be funded by ingredient suppliers ( we disclose this ), we are always dedicated to sharing findings from reputable third-party research institutions. We only focus on studies that meet strict standards and can validate the efficacy and safety of the core active ingredients in our formulations. Trust in evidence is Olenphogy's primary principle.
These studies validate the efficacy of the active ingredients and dosages we use. While these studies provide a solid scientific foundation, our "Smarter Formulas" go a step further: We enhance these research outcomes through synergistic combinations and superior bioavailability, thereby optimizing the real-world results.
Our philosophy is simple: We convert laboratory data into effortless daily benefits, building your long-term "physical reserve capacity".
Smarter Efficiency: We use rigorously screened dosages with high bioavailability to ensure powerful effects while minimizing your metabolic burden.
Time to Effect: While ingredients for acute needs work quickly, achieving systemic balance typically requires continuous use for 4 to 12 weeks.
The Final Feeling: Our formulas are designed for your actual experience. This results in tangible daily benefits: Stable emotions, sustained focus, and a burden-free lightness-effortlessly providing you with valuable life reserve capacity.
These terms confirm the scientific rigor of the research. "Double-blind" studies mean that neither the participants nor the researchers know who took the ingredient, thereby avoiding bias. A low "p-value" indicates that the result is highly unlikely to have occurred by chance. In essence, seeing these terms confirms that the evidence we provide is strong, objective, and trustworthy science-the foundation of all Olenphogy formulas.
Yes, our Research and Development team constantly tracks leading scientific developments globally. Scientific knowledge is constantly evolving, so our formulas are continuously validated and optimized based on the highest quality clinical data. We ensure that you receive the most current, highest quality, and most precise health support available today.
This is a scientific reflection of our commitment to "precisely addressing root causes", rather than just maintaining basic health. Olenphogy's formulas are determined by rigorous ingredient-level research, designed to specifically target underlying issues and imbalances ( such as metabolic support, neurological balance, etc. ) within the body. To achieve perceivable effects and optimize body systems, the effective dose for certain nutrients often needs to exceed the basic 100% of the Daily Value ( DV ). Despite the higher doses, every formula undergoes a safety assessment to verify that the nutrient and ingredient limits are within the acceptable range for long-term use.
Essential Reading
We're committed to evidence-based products and always question the status quo.
